Mon. May 25th, 2026
Spread the love

The Senate has turned down Senator Natasha Akpoti-Uduaghan’s request to return to her legislative duties.
In a letter signed by the Acting Clerk to the National Assembly, Yahaya Danzaria, the lawmakers insisted that the embattled senator’s six-month suspension stands until the Court of Appeal rules on her case.
The Senate acknowledged receiving the senator’s notice that she planned to resume on September 4, 2025, which she said marked the end of her suspension.
However, the Senate pointed out that her suspension started on March 6, 2025, and added that the matter is sub judice since it is already before the Court of Appeal.
“The matter remains sub judice, and until the judicial process is concluded, no administrative action can be taken to facilitate your resumption,” the letter stated.
Senator Akpoti-Uduaghan, who represents Kogi Central, was suspended in March after the Senate accused her of breaching its standing orders.
While the Federal High Court in Abuja upheld the suspension, she appealed to the Court of Appeal.
According to the letter, the Senate will only review her suspension after the court delivers its judgment.
Meanwhile, the lawyer of Natasha Akpoti-Uduaghan, has confirmed that the lawmaker will return to the National Assembly later this month after completing her six-month suspension.
Naija News recalls that Akpoti-Uduaghan was suspended on March 6 following allegations of insubordination for rejecting a designated seat during plenary.
The suspension, based on recommendations of the Senate Committee on Ethics, Privileges and Public Petitions, also stripped her of aides, office privileges, and salaries.
The lawmaker had consistently argued that her ordeal was linked to her petition accusing Senate President, Godswill Akpabio, of sexual harassment, a claim the Senate dismissed.
Natasha later challenged her suspension in court, securing a judgment she said favoured her recall, but the Senate leadership maintained that she would remain suspended until the six-month penalty elapsed.
Her attempt to force her way back into the National Assembly in July ended in a standoff, as security operatives barred her entry despite a crowd of supporters rallying outside.
In an interview with Punch, Natasha’s counsel, Victor Giwa, disclosed that the Senator was on vacation in London but had already made plans to resume plenary alongside her colleagues when the Senate reconvenes on September 23.
The lawyer also stated that the Senate is ready to welcome Natasha and that no obstruction is expected upon her return.
He said, “Actually, she’s ready to resume her term. She’s in London. Everything is in place, and the six months have expired. The only thing left is her resumption.
“We have been told that even the leadership of the Senate is ready to welcome her. So that’s the situation at the moment. There is no obstacle at all.” 
According to Giwa, with the expiration of the suspension on Saturday, September 7, 2025, pending legal disputes would not hinder Natasha’s return to the Senate.
He added, “Everything will be resolved. Even the court cases will become like an academic exercise.” 
The post Senate Rejects Natasha Akpoti-Uduaghan’s Return, Gives Reason appeared first on Naija News.

By admin

You missed

From Tramadol to Canadian to Exol-5 The New Drug Destroying Nigerian Youths An Investigative Article .From Tramadol to Canadian to Exol-5: The New Drug Destroying Nigerian Youths An Investigative Report on the Shifting Landscape of Substance Abuse in Nigeria Nigeria faces a severe and evolving drug crisis, particularly among its youth. What began with the widespread abuse of Tramadol has progressed through mixtures like “Canadian” to newer pharmaceutical diversions such as Exol-5. This shift reflects deeper issues: easy access to prescription drugs, weak regulation, socioeconomic pressures, and aggressive street-level marketing. NDLEA operations and health studies reveal a public health emergency that threatens an entire generation. Phase 1: The Tramadol Epidemic (2010s–Early 2020s) Tramadol, a synthetic opioid prescribed for moderate to severe pain, became Nigeria’s most notorious street drug. Cheap, potent, and widely smuggled (often from India and other Asian countries), it offered users energy, euphoria, and pain relief — appealing to commercial drivers, laborers, students, and young men seeking confidence or stamina. Scale of the Problem: Millions of tablets seized annually by NDLEA. High prevalence among young males aged 15–35. Linked to increased crime, sexual violence, organ damage (kidney failure, seizures), and mental health breakdowns. Contributed to broader opioid misuse alongside codeine cough syrups. Government responses included tighter import controls and public awareness campaigns, but these only displaced demand to other substances rather than eliminating it. Phase 2: The Rise of “Canadian” (Mid-2020s) “Canadian” or “Canadian Loud” emerged as a popular code for high-grade cannabis (often indica-dominant strains) or cannabis mixed with other synthetics. It gained traction as users sought alternatives or combinations to Tramadol’s effects. This phase marked a move toward imported or locally cultivated premium weed, sometimes laced with stronger chemicals. Youths in urban centers like Lagos, Kano, Jos, and Onitsha embraced it for its perceived “cleaner” high compared to opioids. However, it fueled polydrug use — combining cannabis with opioids, sedatives, or alcohol — amplifying health risks. Phase 3: Exol-5 – The Current Threat (2024–2026) Exol-5 (Benzhexol Hydrochloride / Trihexyphenidyl 5mg), originally a prescription medication for Parkinson’s disease and drug-induced movement disorders, has become the latest pharmaceutical being heavily abused. Why Exol-5? Euphoric Effects: Users report intense euphoria, hallucinations, and a sense of detachment — making it attractive as a cheap “upper” or escape. Accessibility: Sold over-the-counter or on the black market despite being a controlled prescription drug. NDLEA has seized millions of pills in single operations (e.g., 3.1 million pills in Kano in late 2024, and over 5.6 million combined with Tramadol in other busts). Street Names: Exol, Artane, Benzhexol, “Farin Mallam” (in Northern Nigeria). Demographics: Prevalent among youths, laborers, and even psychiatric patients who divert prescriptions. Studies show abuse rates as high as 25% among certain outpatient groups. Health Consequences: Anticholinergic toxicity: Confusion, dry mouth, blurred vision, urinary retention, constipation, and in high doses — delirium, psychosis, seizures, and heart issues. Long-term: Cognitive impairment, addiction, exacerbated mental health disorders. Often mixed with Tramadol, codeine, or cannabis, creating dangerous synergies. In cities like Jos, Exol-5 sits alongside diazepam, Rohypnol, and Tramadol on street markets, easily available to teenagers and young adults. Why This Evolution Continues Supply-Side Failures: Porous borders, corrupt officials, and overproduction of pharmaceuticals enable diversion. Demand Drivers: Unemployment, poverty, peer pressure, trauma, and the pursuit of performance enhancement (e.g., for “hustle” culture). Weak Regulation: Many pharmacies sell restricted drugs without prescriptions. Online and street vendors fill gaps. Displacement Effect: Cracking down on one substance (Tramadol/codeine) pushes users and dealers toward the next available option. NDLEA reports ongoing large seizures, but the problem persists due to high profitability and low risk for mid-level distributors. Broader Impacts on Nigerian Youths Education: Increased dropout rates and poor academic performance. Mental Health: Rising cases of psychosis and depression. Economy: Lost productivity among the working-age population. Crime and Violence: Drug-fueled robberies, cultism, and family breakdowns. Public Health System Strain: Overburdened hospitals treating overdoses and chronic complications. Young people aged 15–39 remain the hardest hit, with national surveys showing drug use prevalence significantly above global averages. What Must Be Done Stronger Enforcement: Consistent prosecution of corrupt enablers and large-scale traffickers. Regulation: Crackdown on rogue pharmacies and better tracking of prescription drugs. Prevention & Rehabilitation: School programs, community outreach, and expanded treatment centers (currently woefully inadequate). Economic Alternatives: Address root causes like youth unemployment. Public Awareness: Honest campaigns highlighting real dangers of “Exol-5” and similar drugs. Conclusion From Tramadol’s opioid grip to “Canadian” cannabis culture and now Exol-5’s anticholinergic highs, Nigeria’s drug crisis is mutating faster than responses can contain it. Exol-5 represents the dangerous new frontier — a legitimate medicine turned youth destroyer due to misuse and greed. Without urgent, multi-layered intervention — combining supply disruption, demand reduction, and socioeconomic support — an entire generation risks being lost to addiction. The time for half-measures is over. Nigeria’s future depends on winning this fight.